Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers.
Clinical infectious diseases/Clinical infectious diseases (Online University of Chicago Press)（2023）
关键词
dengue,antiviral small molecule,pan-serotype,first-in-human,dose-escalation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要